Trial of a Selective Acetylcholinesterase Inhibitor, Galanthamine Hydrobromide, in the Treatment of Chronic Fatigue Syndrome
- 1 January 1996
- journal article
- Published by The Haworth Press in Journal of Chronic Fatigue Syndrome
- Vol. 2 (2-3) , 35-54
- https://doi.org/10.1300/j092v02n02_04
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Evidence for Impaired Activation of the Hypothalamic-Pituitary-Adrenal Axis in Patients with Chronic Fatigue SyndromeJournal of Clinical Endocrinology & Metabolism, 1991
- Galanthamine hydrobromide in maniaThe Lancet, 1991
- A Report–Chronic Fatigue Syndrome: Guidelines for ResearchJournal of the Royal Society of Medicine, 1991
- The chronic fatigue syndromeThe American Journal of Medicine, 1991
- Selective inhibition of human acetylcholinesterase by galanthamine in vitro and in vivoLife Sciences, 1990
- Evolving concepts of sleep cycle generation: From brain centers to neuronal populationsBehavioral and Brain Sciences, 1986
- The Cognitive Failures Questionnaire (CFQ) and its correlatesBritish Journal of Clinical Psychology, 1982
- Myasthenia GravisNew England Journal of Medicine, 1978
- Rapid eye movement sleep alterations in myasthenia gravisNeurology, 1976